BRPI0921679A2 - composto útil para tratar celulite - Google Patents

composto útil para tratar celulite

Info

Publication number
BRPI0921679A2
BRPI0921679A2 BRPI0921679A BRPI0921679A BRPI0921679A2 BR PI0921679 A2 BRPI0921679 A2 BR PI0921679A2 BR PI0921679 A BRPI0921679 A BR PI0921679A BR PI0921679 A BRPI0921679 A BR PI0921679A BR PI0921679 A2 BRPI0921679 A2 BR PI0921679A2
Authority
BR
Brazil
Prior art keywords
useful compound
treat cellulite
cellulite
treat
useful
Prior art date
Application number
BRPI0921679A
Other languages
English (en)
Inventor
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of BRPI0921679A2 publication Critical patent/BRPI0921679A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Gerontology & Geriatric Medicine (AREA)
BRPI0921679A 2008-11-11 2009-11-05 composto útil para tratar celulite BRPI0921679A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08168795 2008-11-11
PCT/EP2009/064681 WO2010054978A1 (en) 2008-11-11 2009-11-05 Compound useful for treating cellulite

Publications (1)

Publication Number Publication Date
BRPI0921679A2 true BRPI0921679A2 (pt) 2016-02-16

Family

ID=40427910

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921679A BRPI0921679A2 (pt) 2008-11-11 2009-11-05 composto útil para tratar celulite

Country Status (13)

Country Link
US (2) US20110217252A1 (pt)
EP (1) EP2344153A1 (pt)
JP (1) JP2012508267A (pt)
KR (1) KR20110083628A (pt)
CN (1) CN102209535B (pt)
AU (1) AU2009315771A1 (pt)
BR (1) BRPI0921679A2 (pt)
CA (1) CA2740338A1 (pt)
EA (1) EA019237B1 (pt)
IL (1) IL212212A0 (pt)
MX (1) MX2011004666A (pt)
SG (1) SG195648A1 (pt)
WO (1) WO2010054978A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102309475B (zh) * 2011-07-10 2013-05-15 长春海悦药业有限公司 一种注射用左卡尼汀及其制备方法
EP4772625A2 (en) 2012-01-12 2026-07-08 Endo Biologics Limited Clostridium histolyticum enzyme
US8673325B1 (en) * 2012-09-06 2014-03-18 Dignity Sciences Limited Cosmetic compositions comprising EPA and salicylic acid and methods of making and using same
DK3589204T3 (da) 2017-03-01 2025-06-30 Endo Operations Ltd Apparat og fremgangsmåde til vurdering og behandling af cellulitis
KR20250171475A (ko) 2017-03-28 2025-12-08 엔도 오퍼레이션즈 리미티드 개선된 콜라게나제 생성 방법
CN106943324A (zh) * 2017-05-12 2017-07-14 佛山文森特知识产权服务有限公司 一种祛橘皮纹化妆品组合物
KR102024813B1 (ko) * 2018-09-05 2019-09-26 모아특허법인 지방 분해용 조성물
FR3090380B1 (fr) * 2018-12-20 2021-09-17 Lvmh Rech Extrait de bois de rose
CN110878326A (zh) * 2019-09-30 2020-03-13 广东省农业科学院农业生物基因研究中心 一种增加次生代谢产物曲酸含量的培养基方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
DK0951909T4 (da) * 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
IT1299195B1 (it) * 1998-06-25 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' neuroprotettiva per la prevenzione ed il trattamento delle alterazioni nervose e comportamentali legate a stati
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
IT1306133B1 (it) * 1999-04-22 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
DE10251668A1 (de) * 2002-11-06 2004-05-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Tieftemperaturspeicherung von Suspensionsproben in hängenden Probenkammern
EP1610760A4 (en) * 2003-03-28 2008-01-09 Lonza Ag TOPICAL COMPOSITIONS OF L-CARNITINE
ES2228245B1 (es) * 2003-04-01 2006-06-01 Lipotec, S.A. Composicion para la prevencion y el tratamiento de la celulitis.
US20060058387A1 (en) * 2004-09-15 2006-03-16 Albert Aebi Composition and method for treating skin conditions
WO2006061341A1 (en) * 2004-12-10 2006-06-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of propionyl l-carnitine for the preparation of a high-dose medicament for the treatment of peripheral arterial disease
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
ES2732293T3 (es) * 2007-02-22 2019-11-21 Childrens Hospital & Res Center At Oakland Formulaciones de ácidos grasos y métodos para el uso de las mismas
CN101677912B (zh) * 2007-05-11 2013-06-12 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶

Also Published As

Publication number Publication date
SG195648A1 (en) 2013-12-30
WO2010054978A1 (en) 2010-05-20
EP2344153A1 (en) 2011-07-20
HK1158073A1 (en) 2012-07-13
IL212212A0 (en) 2011-06-30
KR20110083628A (ko) 2011-07-20
EA201170672A1 (ru) 2011-10-31
US20110217252A1 (en) 2011-09-08
CA2740338A1 (en) 2010-05-20
MX2011004666A (es) 2011-05-31
EA019237B1 (ru) 2014-02-28
US20140322149A1 (en) 2014-10-30
JP2012508267A (ja) 2012-04-05
AU2009315771A1 (en) 2010-05-20
CN102209535B (zh) 2013-03-27
CN102209535A (zh) 2011-10-05

Similar Documents

Publication Publication Date Title
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BRPI0914614A2 (pt) 2-arilaminoquinazolinas para tratar doenças proliferativas
ES2397671T8 (es) Procedimiento para preparar voriconazol
BRPI0914789A2 (pt) efeitos sinérgicos
DK2359457T3 (da) Energireducering
BR112012002269A2 (pt) implemento para tratar superfície
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
CR10647S (es) Plancha para peinar el cabello
BRPI1011226A2 (pt) métodos para tratar condições relacionadas ao cabelo
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0920009A2 (pt) composições concentradas para tratamento de superfícies rígidas
BRPI0919127A2 (pt) métodos para tratamento de água
BRPI1008253A2 (pt) Metoso para tratar biomassa
DOS2008000078S (es) Dispositivos para aplicar betun al calzado
BRPI0922884A2 (pt) compostos para tratamento de câncer
CR10645S (es) Plancha para peinar el cabello
BRPI0819633A2 (pt) Métodos para produzir poliolefinas
BR112013013445A2 (pt) composição tópica promotora de melanina
BRPI0822264A2 (pt) Dapsona para tratar rosácea
BR112013008528A2 (pt) métodos para tratar psoríase
BRPI0917866A2 (pt) métodos para intensificar o metabolismo energético
PL2139446T3 (pl) Sposób traktowania włosów
BR112012015447A2 (pt) composição tópica para aplicação cutânea
BRPI0920728A2 (pt) Composição estabilizada para tratamento de psoríase
HRP20160577T1 (hr) Liječenje osteoartritisa

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]